TNFAIP8L2 Produkte
(Tumor Necrosis Factor, alpha-Induced Protein 8-Like 2 (TNFAIP8L2))
Kategorien
Acts as a negative regulator of innate and adaptive immunity by maintaining immune homeostasis. Negative regulator of Toll-like receptor and T-cell receptor function. Prevents hyperresponsiveness of the immune system and maintains immune homeostasis. Inhibits jun/ap1 and NF-kappa-B activation. Promotes Fas-induced apoptosis (By similarity).
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte TNFAIP8L2 Kategorien
TNFAIP8L2 Antikörper
High quality antibodies with extensive validation data.
TNFAIP8L2 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene TNFAIP8L2 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IF, IP
Validierungen
- (5)
Kat. Nr.
ABIN6149298
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
IF
Validierungen
- (3)
Kat. Nr.
ABIN7257315
Menge
200 μL
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
WB, ELISA, IF, ICC
Validierungen
- (2)
Kat. Nr.
ABIN6259461
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene TNFAIP8L2 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
Kat. Nr.
ABIN6234052
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene TNFAIP8L2 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Mouse
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN3129352
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN3074297
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1323137
Menge
10 μg
Datenblatt
Datenblatt
Synonyme und alternative Namen zu TNFAIP8L2
tumor necrosis factor, alpha-induced protein 8-like 2 (Tnfaip8l2), TNF alpha induced protein 8 like 2 (Tnfaip8l2), TNF alpha induced protein 8 like 2 (TNFAIP8L2), Tumor necrosis factor, alpha-induced protein 8-like protein 2 (tp8l2), TNF alpha induced protein 8 like 2 L homeolog (tnfaip8l2.L), tumor necrosis factor, alpha-induced protein 8-like 2a (tnfaip8l2a), TNF alpha induced protein 8 like 2 S homeolog (tnfaip8l2.S), 1810019A08Rik, AW610835, RGD1310519, TIPE2, tipe2, TIPE2 A, tnfaip8l2, tnfaip8l2-a, tnfaip8l2-b, tnfaip8l2b, zgc:136816Bezeichner auf Proteinebene für TNFAIP8L2
- TNF alpha-induced protein 8-like protein 2
- TNFAIP8-like protein 2
- tumor necrosis factor alpha-induced protein 8-like protein 2
- tumor necrosis factor, alpha-induced protein 8-like protein 2
- TIPE2
- inflammation factor 20
- inflammation factor protein 20
- Tumor necrosis factor, alpha-induced protein 8-like protein 2
- tumor necrosis factor, alpha-induced protein 8-like protein 2 a
- TIPE2 B
- TNF alpha-induced protein 8-like protein 2 A
- TNFAIP8-like protein 2 A
- TNFAIP8-like protein 2 B
- tumor necrosis factor, alpha-induced protein 8-like 2
- tumor necrosis factor, alpha-induced protein 8-like protein 2 A
- tumor necrosis factor, alpha-induced protein 8-like protein 2 B
- TNF alpha induced protein 8 like 2 S homeolog
- tumor necrosis factor, alpha-induced protein 8-like protein 2 b
Haben Sie etwas anderes gesucht?
- TNFAIP8L1
- TNFAIP8
- TNFAIP6
- TNFAIP3
- TNFAIP2
- TNFAIP1
- TNF alpha (Placulumab Biosimilar)
- TNF alpha (Ozoralizumab Biosimilar)
- TNF alpha (Nerelimomab Biosimilar)
- TNF alpha (Licaminlimab Biosimilar)
- TNF alpha (Infliximab Biosimilar)
- TNF alpha (Golimumab Biosimilar)
- TNF alpha (Certolizumab Biosimilar)
- TNF alpha (CDP571 Biosimilar)
- TNF alpha (Afelimomab Biosimilar)
- TNF alpha (Adalimumab Biosimilar)
- TNF alpha
- TNF (Etanercept Biosimilar)
- TNC (Tenatumomab Biosimilar)
- TNC
- TNFAIP8L3
- TNFL6
- TNFRSF10A
- TNFRSF10A (Mapatumumab Biosimilar)
- TNFRSF10B
- TNFRSF10B (Conatumumab Biosimilar)
- TNFRSF10B (Drozitumab Biosimilar)
- TNFRSF10B (Lexatumumab Biosimilar)
- TNFRSF10B (Tigatuzumab Biosimilar)
- TNFRSF10B (Tilogotamab Biosimilar)
- TNFRSF11A
- TNFRSF12A
- TNFRSF12A (Enavatuzumab Biosimilar)
- TNFRSF13C
- TNFRSF13C (Ianalumab Biosimilar)
- TNFRSF17 (Belantamab Biosimilar)
- TNFRSF17 (Ispectamab Biosimilar)
- TNFRSF17, CD3E (Alnuctamab Biosimilar)
- TNFRSF17, CD3E (Pacanalotamab Biosimilar)
- TNFRSF17, CD3E (Pavurutamab Biosimilar)
Sie sind hier:
